Teacher Retirement System of Texas Portfolio holdings
AUM
$23.8B
1-Year Return
25.15%
This Quarter Return
+3.56%
1 Year Return
+25.15%
3 Year Return
+104.39%
5 Year Return
+185.58%
10 Year Return
+422.47%
AUM
$27.7B
AUM Growth
+$6.71B
(+32%)
Cap. Flow
+$6.54B
Cap. Flow
% of AUM
23.57%
Top 10 Holdings %
Top 10 Hldgs %
29.7%
Holding
1,710
New
226
Increased
921
Reduced
378
Closed
172
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.2B |
| 2 |
Apple
AAPL
|
+$399M |
| 3 |
NVIDIA
NVDA
|
+$238M |
| 4 |
Microsoft
MSFT
|
+$224M |
| 5 |
Amazon
AMZN
|
+$175M |
Top Sells
| 1 |
iShares MSCI India ETF
INDA
|
+$252M |
| 2 |
Informatica
INFA
|
+$66.6M |
| 3 |
iShares MSCI China ETF
MCHI
|
+$65M |
| 4 |
Franco-Nevada
FNV
|
+$64.8M |
| 5 |
Target
TGT
|
+$51.6M |
Sector Composition
| 1 | Technology | 26.6% |
| 2 | Financials | 12.62% |
| 3 | Consumer Discretionary | 11.25% |
| 4 | Healthcare | 10.38% |
| 5 | Industrials | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Atmos Energy
ATO
$26.3B
| $202K | ﹤0.01% |
1,452
-7,147
| -83% | -$994K |
|
1477
Texas Pacific Land
TPL
$20.7B
| $202K | ﹤0.01% |
+183
| New | +$202K |
|
1478
Zymeworks
ZYME
$1.15B
| $201K | ﹤0.01% |
13,743
+2,216
| +19% | +$32.4K |
|
1479
Yext
YEXT
$1.06B
| $197K | ﹤0.01% |
30,987
+1,410
| +5% | +$8.96K |
|
1480
Vir Biotechnology
VIR
$728M
| $194K | ﹤0.01% |
26,440
+2,556
| +11% | +$18.8K |
|
|
MAGN
1481
Magnera Corporation
MAGN
$417M
| $193K | ﹤0.01% |
+10,624
| New | +$193K |
|
1482
Liquidia Corp
LQDA
$2.39B
| $192K | ﹤0.01% |
16,322
+4,825
| +42% | +$56.8K |
|
1483
89bio
ETNB
$1.28B
| $191K | ﹤0.01% |
24,442
+6,521
| +36% | +$51K |
|
1484
Ironwood Pharmaceuticals
IRWD
$180M
| $190K | ﹤0.01% |
42,893
+7,020
| +20% | +$31.1K |
|
1485
Pliant Therapeutics
PLRX
$107M
| $190K | ﹤0.01% |
14,451
+2,347
| +19% | +$30.9K |
|
1486
Replimune Group
REPL
$454M
| $189K | ﹤0.01% |
+15,603
| New | +$189K |
|
1487
Neumora Therapeutics
NMRA
$270M
| $177K | ﹤0.01% |
+16,669
| New | +$177K |
|
1488
Nuvation Bio
NUVB
$1.15B
| $172K | ﹤0.01% |
64,502
+27,231
| +73% | +$72.6K |
|
1489
Crawford & Co Class A
CRD.A
$516M
| $171K | ﹤0.01% |
14,817
+43
| +0.3% | +$496 |
|
1490
Apple Hospitality REIT
APLE
$2.99B
| $169K | ﹤0.01% |
11,018
-3,317
| -23% | -$50.9K |
|
1491
Evolus
EOLS
$478M
| $155K | ﹤0.01% |
14,084
+2,302
| +20% | +$25.3K |
|
1492
Altimmune
ALT
$334M
| $153K | ﹤0.01% |
21,205
+3,423
| +19% | +$24.7K |
|
1493
Similarweb
SMWB
$840M
| $153K | ﹤0.01% |
+10,796
| New | +$153K |
|
1494
Aveanna Healthcare
AVAH
$1.73B
| $151K | ﹤0.01% |
+33,046
| New | +$151K |
|
1495
Prothena Corp
PRTA
$449M
| $145K | ﹤0.01% |
+10,434
| New | +$145K |
|
1496
Capricor Therapeutics
CAPR
$296M
| $141K | ﹤0.01% |
+10,243
| New | +$141K |
|
1497
Cogent Biosciences
COGT
$1.79B
| $140K | ﹤0.01% |
17,983
+2,396
| +15% | +$18.7K |
|
1498
Liberty Global Class C
LBTYK
$4B
| $139K | ﹤0.01% |
+10,596
| New | +$139K |
|
1499
Relay Therapeutics
RLAY
$702M
| $139K | ﹤0.01% |
33,720
+5,492
| +19% | +$22.6K |
|
1500
Arbutus Biopharma
ABUS
$830M
| $138K | ﹤0.01% |
42,144
+6,644
| +19% | +$21.8K |
|